Showing 1 - 20 results of 65 for search '"криоглобулинемия"', query time: 0.92s Refine Results
  1. 1
    Academic Journal

    Source: Aktualʹnaâ Infektologiâ, Vol 4, Iss 3.12, Pp 52-56 (2016)
    ACTUAL INFECTOLOGY; № 3.12 (2016); 52-56
    Актуальная инфектология-Aktualʹnaâ Infektologiâ; № 3.12 (2016); 52-56
    Актуальна інфектологія-Aktualʹnaâ Infektologiâ; № 3.12 (2016); 52-56

    File Description: application/pdf

  2. 2
  3. 3
    Academic Journal

    Source: Siberian Journal of Clinical and Experimental Medicine; Том 37, № 4 (2022); 87-94 ; Сибирский журнал клинической и экспериментальной медицины; Том 37, № 4 (2022); 87-94 ; 2713-265X ; 2713-2927

    File Description: application/pdf

    Relation: https://www.sibjcem.ru/jour/article/view/1623/761; Беляева И.Б., Зоткин Е.Г., Лила А.М., Мазуров В.И., Онущенко И.А. Диффузные болезни соединительной ткани: руководство для врачей. М.: Медицинская книга; 2011:248.; Karlsberg P.L., Lee W.M., Casey D.L., Cockerell C.J., Cruz P.D. Jr. Cutaneous vasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus-induced mixed cryoglobulinemia. Arch. Dermatol. 1995;131(10):1119–1123.; Cacoub P., Poynard T., Ghillani P., Charlotte F., Olivi M., Piette J.C. et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum. 1999;42(10):2204–2212. DOI:10.1002/1529-0131(199910)42:103.0.CO;2-D.; Cacoub P., Renou C., Rosenthal E., Cohen P., Loury I., Loustaud-Ratti V. et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine (Baltimore). 2000;79(1):47–56. DOI:10.1097/00005792-200001000-00005.; Stefanova-Petrova D.V., Tzvetanska A.H., Naumova E.J., Mihailova A.P., Hadjiev E.A., Dikova R.P. et al. Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients. World J. Gastroenterol. 2007;13(48):6518– 6528. DOI:10.3748/wjg.v13.i48.6518.; Ramos-Casals M., Forns X., Brito-Zerón P., Vargas A., Ruiz M., Laguno M. et al. Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection. J. Viral. Hepat. 2007;14(10):736–742. DOI:10.1111/j.1365-2893.2007.00866.x.; Aguiar M.F., Faria-Janes A.L., Garcia-Brandes G.I., Takemi-Emori C., Ferraz M.L.G., Andrade L.E.C. et al. Prevalence of cryoglobulinemia and cryoglobulinemic vasculitis in chronically HCV-infected Brazilian patients. Ann. Hepatol. 2019;18(5):685–692. DOI:10.1016/j.aohep.2019.04.010.; Della Rossa A., Tavoni A., D’Ascanio A., Catarsi E., Marchi F., Bencivelli W. et al. Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus. Scand. J. Rheumatol. 2010;39(2):167– 170. DOI:10.3109/03009740903313639.; Terrier B., Sène D., Dechartres A., Saadoun D., Ortonne N., Rouvier P. et al. Systemic vasculitis in patients with hepatitis C virus infection with and without detectable mixed cryoglobulinemia. J. Rheumatol. 2011;38(1):104–110. DOI:10.3899/jrheum.100191.; Dammacco F., Lauletta G., Vacca A. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements. Clin. Exp. Med. 2022:1–18. DOI:10.1007/s10238-022-00808-1.; Клинические рекомендации. ВИЧ-инфекция у взрослых. URL: https://cr.minzdrav.gov.ru/recomend/79_1; Неустроева Ю.А., Тихомирова Т.А., Дунаева Н.В., Лапин С.В., Тотолян А.А. Оптимизация полуколичественного метода выявления криоглобулинов в условиях клинико-диагностической лаборатории. Клиническая лабораторная диагностика. 2007;(1):37–41.; Константинова Н.А. Криоглобулины и патология. М.: Медицина; 1999:176.; Muratori L., Gibellini D., Lenzi M., Cataleta M., Muratori P., Morelli M.C. et al. Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood. 1996;88(7):2768–2774.; Bernardin F., Tobler L., Walsh I., Williams J.D., Busch M., Delwart E. Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia. Hepatology. 2008;47(5):1446–1452. DOI:10.1002/hep.22184.; Toubi E., Gordon S., Kessel A., Rosner I., Rozenbaum M., Shoenfeld Y. et al. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. J. Autoimmun. 2006;27(2):134–139. DOI:10.1016/j.jaut.2006.07.005.; Liao T.L., Chen Y.M., Hsieh S.L., Tang K.T., Chen D.Y., Yang Y.Y. et al. Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor. mBio. 2021;12(6):e0276421. DOI:10.1128/mBio.02764-21.; Brouet J.C., Clauvel J.P., Danon F., Klein M., Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am. J. Med. 1974;57(5):775–788. DOI:10.1016/0002-9343(74)90852-3.; Minopetrou M., Hadziyannis E., Deutsch M., Tampaki M., Georgiadou A., Dimopoulou E. et al. Hepatitis C virus (HCV)-related cryoglobulinemia: cryoglobulin type and anti-HCV profile. Clin. Vaccine Immunol. 2013;20(5):698–703. DOI:10.1128/CVI.00720-12.; Дунаева Н.В., Мазинг А.В., Лапин С.В., Гусев Д.А. Частота регистрации смешанной криоглобулинемии и ее значение в развитии внепеченочных проявлений при хроническом гепатите С и при коинфекции хронический гепатит С/ВИЧ-инфекция. Инфекционные болезни: новости, мнения, обучение. 2022;11(2):69–76. DOI:10.33029/2305-3496-2022-11-2-69-76.; Sansonno D., Tucci F.A., Ghebrehiwet B., Lauletta G., Peerschke E.I., Conteduca V. et al. Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage. J. Immunol. 2009;183(9):6013–6020. DOI:10.4049/jimmunol.0902038.; Sansonno D., Carbone A., De Re V., Dammacco F. Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford). 2007;46(4):572–578. DOI:10.1093/rheumatology/kel425.; Saadoun D., Terrier B., Semoun O., Sene D., Maisonobe T., Musset L. et al. Hepatitis C virus-associated polyarteritis nodosa. Arthritis Care Res (Hoboken). 2011;63(3):427–435. DOI:10.1002/acr.20381.; Ramos-Casals M., Robles A., Brito-Zerón P., Nardi N., Nicolás J.M., Forns X. et al. Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases. Semin. Arthritis Rheum. 2006;36(3):189–196. DOI:10.1016/j.semarthrit.2006.08.005.; https://www.sibjcem.ru/jour/article/view/1623

  4. 4
  5. 5
    Academic Journal

    Source: Meditsinskiy sovet = Medical Council; № 21 (2019); 248-253 ; Медицинский Совет; № 21 (2019); 248-253 ; 2658-5790 ; 2079-701X ; 10.21518/2079-701X-2019-21

    File Description: application/pdf

    Relation: https://www.med-sovet.pro/jour/article/view/5501/5020; Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–171. doi:10.1016/S0140-6736(14)61682-2.; Lee M.H., Yang H.I., Lu S.N., Jen C.L., You S.L., Wang L.Y., et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J. Infect.Dis. 2012;206(4):469–477. doi:10.1093/infdis/jis385.; Younossi Z., Park H., Henry L., Adeyemi A., Stepanova M. Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden. Gastroenterology. 2016;150(7):1599–1608. doi:10.1053/j.gastro.2016.02.039.; Monaco S., Mariotto S., Ferrari S., Calabrese M., Zanusso G., Gajofatto A., et al. Hepatitis C virusassociated neurocognitive and neuropsychiatric disorders: Advances in 2015. World Journal of Gastroenterology. 2015;21(42):11974–11983. doi:10.3748/wjg.v21.i42.11974.; Byrnes V., Miller A., Lowry D., Hill E., Weinstein C., Alsop D., et al. Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition. Journal of Hepatology. 2012;56(3):549–556. doi:10.1016/j.jhep.2011.09.015.; Morgello S., Murray J., Van Der Elst S., Byrd D. HCV, but not HIV, is a risk factor for cerebral small vessel disease. Neurology: Neuroimmuno logy&Neuroinflammation. 2014;1(3):e27. doi:10.1212/NXI.0000000000000027.; Enger C., Forssen U.M., Bennett D., Theodore D., Shantakumar S., McAfee A. Thromboembolic events among patients with hepatitis C virus infection and cirrhosis: a matched-cohort study. Advances in Therapy. 2014;31(8):891–903. doi:10.1007/s12325-014-0138-4.; Liao C.C., Su T.C., Sung F.C., Chou W.H., Chen T.L. Does hepatitis C virus infection increase risk for stroke? A population-based cohort study. PLoS ONE. 2012;7(2):e31527. doi:10.1371/journal.pone.0031527.; Huang H., Kang R., Zhao Z. Hepatitis C virus infection and risk of stroke: a systematic review and meta-analysis. PLoS ONE. 2013;8(11):e81305. doi:10.1371/journal.pone.0081305.; Wong R.J., Gish R.G. Metabolic manifestations and complications associated with chronic hepatitis C virus infection. Gastroenterology and Hepatology. 2016;12(5):293–299. Available at: https://www.gastroenterologyandhepatology.net/archives/may-2016/metabolic-manifestations-and-complications-associated-withchronic-hepatitis-c-virus-infection/; Naing C., Mak J.W., Ahmed S.I., Maung M. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis. World Journal of Gastroenterology. 2012;18(14):1642–1651. doi:10.3748/wjg.v18.i14.1642.; Chandra P.K., Hazari S., Poat B., Gunduz F., Prabhu R., Liu G., et al. Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone. Virol. J. 2010;7:118. doi:10.1186/1743-422X-7-118.; Ostojic P., Jeremic I.R. Managing refractory cryoglobulinemic vasculitis: challenges and solutions. Journal of Inflammation Research. 2017;10:49–54. doi:10.2147/JIR.S114067.; Cacoub P., Comarmond C., Domont F., Savey L., Desbois A.C., Saadoun D. Extrahepatic manifestation of chronic hepatitis C virus infection. Therapeutic Advances in Infectious Disease. 2016;3(1):3–14. doi:10.1177/2049936115585942.; Стельмах В.В., Козлов В.К., Суханов Д.С., Скипский И.М. Васкулит легких как клиниче- ская «маска» HCV-инфекции: эффективность безинтерфероновой противовирусной тера- пии. Терапевтический архив. 2014;11:87–92. Режим доступа: https://www.mediasphera.ru/issues/terapevticheskij-arkh; iv/2014/11/030040-366020141117. Stel’mah V.V., Kozlov V.K., Sukhanov D.S., Skipskij I.M. Pulmonary vasculitis as a clinical mask of HCV infection: Efficiency of interferon-free antiviral therapy. Therapeutic archive = Terapevticheskiy arkhiv. 2014;11:87–92. (In Russ.) Available at: https://www.mediasphera.ru/issues/terapevticheskij-arkhiv/2014/11/030040-366020141117.; Retamozo S., Díaz-Lagares C., Bosch X., Bové A., Brito-Zerón P., Gómez M.E., et al. Life- threatening cryoglobulinemic patients with hepatitis C: clinical description and outcome of 279 patients. Medicine. 2013;92(5):273–284. doi:10.1097/MD.0b013e3182a5cf71.; Terrier B., Cacoub P. Renal involvement in HCV-related vasculitis. Clin. Res. Hepatol. Gastroenterol. 2013;37(4):334–339. doi:10.1016/j.clinre.2013.02.002; Tang L., Marcell L., Kottilil S. Systemic manifestations of hepatitis C infection. Infectious Agents and Cancer. 2016;11:29. doi:10.1186/s13027-016-0076-7.; Perico N., Cattaneo D., Bikbov B., Remuzzi G. Hepatitis C infection and chronic renal diseases. Clin. J. Amer. Soc. Nephrol. 2009;4(1):207–220. doi:10.2215/CJN.03710708.; Fabrizi F., Verdesca S., Messa P., Martin P. Hepatitis C virus infection increases the risk of developing chronic kidney disease: A systematic review and meta-analysis. Digestive Diseases and Sciences. 2015;60(12):3801–3813. doi:10.1007/s10620-015-3801-y.; Fabrizi F., Dixit V., Messa P. Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality? J Viral Hepat. 2012;19(9):601–607. doi:10.1111/j.1365-2893.2012.01633.x.; Shen Y., Wang X.L., Xie J.P., Shao J.G., Lu Y.H., Zhang S., Qin G. Thyroid disturbance in patients with chronic hepatitis C infection: a systematic review and meta-analysis. Journal of gastrointestinal and liver diseases. 2016;25(2):227–234. doi:10.15403/jgld.2014.1121.252.chc.; Blackard J.T., Kong L., Huber A.K., Tomer Y. Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of HCV and thyroiditis analysis. Thyroid. 2013;23(7):863–870. doi:10.1089/thy.2012.0507.; Raphael B.A., Dorey-Stein Z.L, Lott J., Amorosa V., Lo Re V 3rd, Kovarik C. Low prevalence of necrolytic acral erythema in patients with chronic hepatitis C virus infection. J Am Acad Dermatol. 2012;67(5):962–968. doi:10.1016/j.jaad.2011.11.963.; Moneib H.A.M., Salem S.A.M., Darwish M.M. Evaluation of zinc level in skin of patients with necrolytic acral erythema. Br J Dermatol. 2010;163(3):476–480. doi:10.1111/j.1365-2133.2010.09820.x.; Raslan H.M., Ezzat W.M., Abd El Hamid M.F., Emam H., Amre K.S. Skin manifestationsof chronic hepatitis C virus infection in Cairo, Egypt. East Mediterr Health J. 2009;15(3):692–700. Available at: http://www.emro.who.int/emhj-volume-15-2009/volume-15-issue-3/skin-manifestations-of-chronic-hepatitis-cvirus-infection-in-cairo-egypt.html.; Petti S., Rabiei M., De Luca M., Scully C. The magnitude of the association between hepatitis C virus infection and oral lichen planus: meta-analysis and case control study. Odontology. 2011;99(2):168–178. doi:10.1007/s10266-011-0008-3.; Pothineni N.V., Delongchamp R., Vallurupalli S., Ding Z., Dai Y., Hagedorn C.H., Mehta J.L. Impact of hepatitis C seropositivity on the risk of coronary heart disease events. American Journal of Cardiology. 2014;114(12):1841–1845. doi:10.1016/j.amjcard.2014.09.020.; Gill K., Ghazinian H., Manch R., Gish R. Hepatitis C virus as a systemic disease: Reaching beyond the liver. Hepatology International. 2016;10(3):415–423. doi:10.1007/s12072-015-9684-3.; Hsu Y.C., Ho H.J., Huang Y.T., Wang H.H., Wu M.S., Lin J.T., Wu C.Y. Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection. Gut. 2015;64(3):495–503. doi:10.1136/gutjnl-2014-308163.; Domont F., Cacoub P. Chronic hepatitis C virus infection, a new cardiovascular risk factor? Liver International. 2016;36(5):621–627. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26763484.; Huang H., Kang R., Zhao Z. Is hepatitis C associated with atherosclerotic burden? A systematic review and meta-analysis. PLoS ONE. 2014;9(9):e106376. doi:10.1371/journal.pone.0106376.; Adinolfi L.E., Zampino R., Restivo L., Lonardo A., Guerrera B., Marrone A., et al. Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms. World Journal of Gastroenterology. 2014;20(13):3410–3417. doi:10.3748/wjg.v20.i13.3410.; Boddi M., Abbate R., Chellini B., Giusti B., Giannini C., Pratesi G., et al. Hepatitis C virus RNA localization in human carotid plaques. Journal of Clinical Virology. 2010;47(1):72–75. doi:10.1016/j.jcv.2009.10.005

  6. 6
    Academic Journal

    Source: Pathologia; Vol. 16 No. 1 (2019): Pathologia ; Патология; Том 16 № 1 (2019): Патологія ; Патологія; Том 16 № 1 (2019): Патологія ; 2310-1237 ; 2306-8027

    File Description: application/pdf

  7. 7
    Academic Journal

    Source: Bulletin of Scientific Research; No 3 (2016) ; Вестник научных исследований; № 3 (2016) ; Вісник наукових досліджень; № 3 (2016) ; 2415-8798 ; 1681-276X ; 10.11603/2415-8798.2016.3

    File Description: application/pdf

  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
    Academic Journal

    Relation: Лукашик, С. П. Полиморфизм проявлений смешанной криоглобулинемии при хронической инфекции, вызванной вирусом гепатита С / С. П. Лукашик, И. А. Карпов О. В. Красько // Проблемы здоровья и экологии. – 2021. – Т. 18, № 1. – С. 160-169.; http://elib.gsmu.by/handle/GomSMU/8290; https://doi.org/10.51523/2708-6011.2021-18-1-21

  15. 15
    Academic Journal

    Source: Medical Immunology (Russia); Том 9, № 6 (2007); 575-580 ; Медицинская иммунология; Том 9, № 6 (2007); 575-580 ; 2313-741X ; 1563-0625 ; 10.15789/1563-0625-2007-6

    File Description: application/pdf

    Relation: https://www.mimmun.ru/mimmun/article/view/243/245; Константинова Н.А. Криоглобулины и патология. – М.: Медицина, 1999. – 176 с.; Игнатова Т.М., Апросина З.Г., Серов В.В., Мухин Н.А., Крель П.Е., Семенкова Е.Н., Попова И.В., Танащук Е.Л. Внепеченочные проявления хронического вирусного гепатита С // Терапевт. арх. – 1998. – № 11. – C. 9-16.; Неустроева Ю.А., Тихомирова Т.А., Дунаева Н.В., Лапин С.В., Тотолян А.А. Оптимизация полуколичественного метода выявления криоглобулинов в условиях клинико-диагностической лаборатории // Клин. лаб. диагностика. – 2007. – № 1. – С. 37-41.; Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection // Springer Semin. Immunopathol. – 1997. – Vol. 19, N 1. – P. 111-129.; Almirall J., Amengual M.J., Lopez T., Andreu X., Oristrell J., Sala M., Luelmo J., Dalmau B. Type II essential mixed cryoglobulinemia and renal disease. Hepatitis C virus association // Nefrologia. – 2002. – Vol. 22, N 6. – P. 531-539.; Antonescu C., Mayerat C., Mantegani A., Frei P.C., Spertini F., Tissot J.-D. Hepatitis C virus (HCV) infection: serum rheumatoid factor activity and HCV genotype correlate with cryoglobulin clonality // Blood. – 1998. – Vol. 92, N 9. – P. 3486-3488.; Cicardi M., Cesana B., Del Ninno E., Pappalardo E., Silini E., Agostoni A., Colombo M. Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C // J. Viral Hepat. – 2000. – Vol. 7, N 2. – P. 138-143.; D’Amico G., Fornasieri A. Cryoglobulinemia // Therapy in nephrology and hypertension: a companion to Brenner and Rector’s The kidney / Ed. by Brady H.R., Wilcox C.S. – USA: W.B.Saunders Company, 1999. – Chap. 18. – P. 125-129.; Ducoulombier D., Roque-Afonso A.-M., Di Liberto G., Penin F., Kara R., Richard Y., Dussaix E., Feray C. Frequent compartmentalization of hepatitis C virusvariants in circulating B cells and monocytes // Hepatology. – 2004. – Vol. 39. – P. 817-825.; Ferri C., Giuggioli D., Cazzato M., Sebastiani M., Mascia M.T., Zignego A.L. HCV-related cryoglobulinemic vasculitis: an update on its etiopathogenesis and therapeutic strategies // Clin. Exp. Rheumatol. – 2003. – Vol. 21, Suppl. 31. – P. 78-84.; Ferri C., Sebastiani M., Giuggioli D., Cazzato M., Longombardo G., Antonelli A., Puccini R., Michelassi C., Zignego A.L. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients // Semin. Arthritis Rheum. – 2004. – Vol. 33, N 6. – P. 355-374.; Frangeul L., Musset L., Cresta P., Cacoub P., Huraux J.M., Lunel F. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia // J. Hepatol. – 1996. – Vol. 25, N 4. – P. 427-432.; Gad A., Tanaka E., Matsumoto A., el-Hamid Serwah A., Ali K., Makledy F., el-Gohary A., Orii K., Ijima A., Rokuhara A., Yoshizawa K., Nooman Z., Kiyosawa K. Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: ethnic and genotypic influence // J. Med. Virol. – 2003. – Vol. 70, N 4. – P. 594-599.; Hilgard P., Treichel U., Dries V., Dienes H.P., Gerken G. Cryoglobulin-associated uptake of hepatitis C virus into human hepatocytes // Hepatogastroenterology. – 2005. – Vol. 52, N 65. – P. 1534-1540.; Hwang S.-J., Chu C.-W., Huang D.-F., Lan K.-H., Chang F.-Y., Lee S.-D. Genetic predispositions for the presence of cryoglobulinemia and serum autoantibodies in Chinese patients with chronic hepatitis C // Tissue Antigens. – 2002. – Vol. 59. – P. 31-37.; Iagnocco A., Coari G., Mammarella M., Basili S., Donnarumma L., Valesini G., Paoletti V. Joint sonographi in asymptomatic patients with HCV correlated hepatitis // Clin. Exp. Rheumatology. – 2004. – Vol. 22, N 1. – P. 43-48.; Kayali Z., Buckwold V.E., Zimmerman B., Schmidt W.N. Hepatitis C, cryoglobulinemia and cirrhosis: a meta-analysis // Hepatology. – 2002. – Vol. 36, N 4. – P. 978-985.; Kosmas N., Kontos A., Panayiotakopoulos G., Dimitrakopoulos A., Kordossis T. Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV-positive, HCV-negative patients // J. Med. Virol. – 2006. – Vol. 78, N 10. – P. 1257-1261.; Kronenberger B., R ster B., Elez R., Weber S., Piiper A., Lee J.-H., Roth W.K., Zeuzem S. Interferon alfa down-regulates CD81 in patients with chronic hepatitis C // Hepatology. – 2001. – Vol. 33, N 6. – P. 1518-1526.; Liakina V., Speiciene D., Irnius A., Naraskeviciene J., Barakauskiene A., Semuchiniene T. Prevalence of cryoglobulinemia in patients with chronic HCV infection // Med. Sci. Monit. – 2002. – Vol. 8, N 1. – P. 31-36.; Lunel F., Musset L., Cacoub P., Frangeul P., Cresta P., Perrin M., Grippon P., Hoang C., Piette J.C., Huraux J.-H., Opolon P. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage // Gastroenterology. – 1994. – Vol. 106. – P. 1291-1300.; Moldvay J., Deny P., Pol S., Brechot C., Lamas E. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization // Blood. – 1994. – Vol. 83, N 1. – P. 269-273.; Morsica G., Tambussi G., Sitia G., Novati R., Lazzarin A., Lopalco L., Mukenge S. Replication of hepatitis C virus in B lymphocytes (CD19+) // Blood. – 1999. – Vol. 94, N 3. – P. 1138-1139.; Muratori L., Gibellini D., Lenzi M., Cataleta M., Muratori P., Morelli M.C., Bianchi F.B. Quantification of hepatitis C virus infected peripheral blood mononuclear cells by in situ reverse transcriptasepolymerase chain reaction // Blood. – 1996. – Vol. 88, N 7. – P. 2768-2774.; Pascual M., Perrin L., Giostra E., Schifferli J. Hepatitis C virus in patients with cryoglobulinaemia type II // J. Infect. Dis. – 1990. – Vol. 162. – P. 569-570.; Pawlotsky J.-M., Ben Yahia M., Andre C., Voisin M.-C., Intrator L., Roudot-Thoraval F., Deforges L., Duvoux C., Zafrani E-S., Duval J., Dhumeaux D. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study // Hepatology. – 1994. – Vol. 19, N 4. – P. 841-848.; Rizos E., Dimos G., Liberopoulos E.N., Elisaf M.S., Drosos A.A. Cryoglobulinemic purpura in visceral leishmaniasis // Rheumatol. Int. – 2005. – Vol. 25, N 6. – P. 469-471.; Saadoun D., Sellam J., Ghillani-Dalbin P., Crecel R., Piette J.-C., Cacoub P. Increased risks of lymphoma and death among patients with non-hepatitis C virusrelated mixed cryoglobulinemia // Arch. Intern. Med. – 2006. – Vol. 166. – P. 2101-2108.; Saadoun D., Asselah T., Resche-Rigon M., Charlotte F., Bedossa P., Valla D., Piette J.C., Marcellin P., Cacoub P. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C // Hepatology. – 2006. – Vol. 43, N 6. – P. 1337-1345.; Schmidt W.N., Stapleton J.T., LaBrecque D.R., Mitros F.A., Kirby P.A., Phillips M., Brashear D. Hepatitis C virus (HCV) infection and cryoglobulinemia: analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology // Hepatology. – 2000. – Vol. 31. – P. 737-744.; Trejo O., Ramos-Casals M., Lopez-Guillermo A., Garcia-Carrasco M., Yagie J., Cervera R., Font J., Ingelmo M. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases // Semin. Arthritis Rheum. – 2003. – Vol. 33, N 1. – P. 19-28.; Wintrobe M., Buell M. Hyperproteinemia associated with multiple myeloma. With report of a case in with anextraordinary hyperproteinemia was associated with thrombosis of the retinal veins and symptoms suggesting Raynaud’s disease // Bull. of the John Hopkins Hosp. – 1933. – Vol. 52. – P. 156-165.; Wong V.S., Egner W., Elsey T., Brown D., Alexander G.J. Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C virus infection // Clin. Exp. Immunol. – 1996. – Vol. 104, N 1. – P. 25-31.; Zignego A.L., Ferri C., Giannini C., Monti M., La Civita L., Careccia G., Longombardo G., Lombardini F., Bombardieri S., Gentilini P. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia // Ann. Intern. Med. – 1996. – Vol. 124, Iss. 1, Part 1. – P. 31-34.; https://www.mimmun.ru/mimmun/article/view/243

  16. 16
  17. 17
  18. 18
  19. 19
  20. 20